Basal Cell Carcinoma — Trials

Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 16.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (25)

clinicaltrialsPublishedShowing 51–59 of 59 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00079300	Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer	completed	Phase 1	—	National Naval Medical CenterFED	1	Apr 26, 2013	clinicaltrials
NCT00089362	Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	Apr 10, 2013	clinicaltrials